OKYO Pharma Ltd. Form 6-K Summary
Business Context and Reporting Period
OKYO Pharma Ltd, a foreign private issuer filing annual reports on Form 20-F, furnished this Form 6-K on August 19, 2022. The filing relates to a UK news service announcement issuing the notice of the company’s annual general meeting.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance metrics.
Material Changes Versus Prior Period
No operating or financial changes versus a prior comparable period are disclosed.
Guidance, Outlook, Risks, and Unusual Items
The filing contains no financial guidance, business outlook, risk update, contingencies, or unusual items. Exhibit 99.1 is identified as the notice-related news service announcement, but its substantive contents are not included in the provided filing text.
Important Facts to Verify
- Review Exhibit 99.1 for the annual general meeting date, location or access details, agenda, voting procedures, and shareholder deadlines.
- Confirm whether the AGM notice contains proposed resolutions or other corporate actions.
- Note that the announcement is furnished rather than filed under Section 18 of the Securities Exchange Act and is not incorporated by reference unless expressly stated in another filing.